TP53 and cancer: Since our previous studies have shown HS promotes mitochondrial apoptosis pathway activation in p53-deficient cancer cells (H1299 p53-/- cells)9, further studies investigating the underlying mechanisms of Pin1 and p53 transcription-independent apoptotic activity were performed in H1299 p53-/- cells.